Thanks Rothbard. I was eagerly awaiting your report, and it has arrived in its usual thorough state.
The meeting seems to have had no impact on bids/offers. I was a little disappointed to read that we still seem to be losing money in quarter one (described as "challenging") but it's been clear for some time that we shouldn't expect much in the way of profits until 2021/22. In the meantime, we need to be patient. Like you, I think they are on the right track.
Was there any news as to the progress of reaching agreement with a US distributor, as we seem to have been in negotiations for an extended time
Also...I'm just curious...how many folks were there?
.
Anyway, thanks again for a great report!
- Forums
- ASX - By Stock
- SRH
- Ann: Chairman's & CEO's Address to Shareholders
Ann: Chairman's & CEO's Address to Shareholders, page-3
-
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SRH (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.791M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
SRH (ASX) Chart |
Day chart unavailable
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online